WO2005041893A3 - Detection des biomarqueurs de l'infarctus aigu du myocarde - Google Patents

Detection des biomarqueurs de l'infarctus aigu du myocarde Download PDF

Info

Publication number
WO2005041893A3
WO2005041893A3 PCT/US2004/036381 US2004036381W WO2005041893A3 WO 2005041893 A3 WO2005041893 A3 WO 2005041893A3 US 2004036381 W US2004036381 W US 2004036381W WO 2005041893 A3 WO2005041893 A3 WO 2005041893A3
Authority
WO
WIPO (PCT)
Prior art keywords
myocardial infarction
acute myocardial
detection
biomarkers
patient
Prior art date
Application number
PCT/US2004/036381
Other languages
English (en)
Other versions
WO2005041893A2 (fr
Inventor
Ronald J Shebuski
Arthur Raymond Kydd
Hiroshi Nomura
Original Assignee
Queststar Medical Inc
Ronald J Shebuski
Arthur Raymond Kydd
Hiroshi Nomura
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queststar Medical Inc, Ronald J Shebuski, Arthur Raymond Kydd, Hiroshi Nomura filed Critical Queststar Medical Inc
Publication of WO2005041893A2 publication Critical patent/WO2005041893A2/fr
Publication of WO2005041893A3 publication Critical patent/WO2005041893A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
    • C08J7/04—Coating
    • C08J7/0427—Coating with only one layer of a composition containing a polymer binder
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
    • C08J7/12—Chemical modification
    • C08J7/16—Chemical modification with polymerisable compounds
    • C08J7/18—Chemical modification with polymerisable compounds using wave energy or particle radiation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D1/00—Processes for applying liquids or other fluent materials
    • B05D1/62—Plasma-deposition of organic layers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2433/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Abstract

L'invention concerne des procédés et des dispositifs médicaux de détection précoce de l'infarctus aigu du myocarde chez un patient. Plus particulièrement, l'invention concerne un dispositif et un procédé de détection de la présence d'analytes de biomarqueurs dans un échantillon, lesquels indiquent un risque d'infarctus aigu du myocarde chez le patient.
PCT/US2004/036381 2003-10-31 2004-11-01 Detection des biomarqueurs de l'infarctus aigu du myocarde WO2005041893A2 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US51665603P 2003-10-31 2003-10-31
US51665403P 2003-10-31 2003-10-31
US51665503P 2003-10-31 2003-10-31
US60/516,656 2003-10-31
US60/516,655 2003-10-31
US60/516,654 2003-10-31

Publications (2)

Publication Number Publication Date
WO2005041893A2 WO2005041893A2 (fr) 2005-05-12
WO2005041893A3 true WO2005041893A3 (fr) 2005-11-24

Family

ID=34557383

Family Applications (3)

Application Number Title Priority Date Filing Date
PCT/US2004/036381 WO2005041893A2 (fr) 2003-10-31 2004-11-01 Detection des biomarqueurs de l'infarctus aigu du myocarde
PCT/US2004/036382 WO2005043123A2 (fr) 2003-10-31 2004-11-01 Systeme et appareil pour l'analyse de fluides biologiques utilisant des materiaux optiques textures en surface
PCT/US2004/036460 WO2005042795A2 (fr) 2003-10-31 2004-11-01 Polymerisation par plasma de surfaces ayant subi une modification atomique

Family Applications After (2)

Application Number Title Priority Date Filing Date
PCT/US2004/036382 WO2005043123A2 (fr) 2003-10-31 2004-11-01 Systeme et appareil pour l'analyse de fluides biologiques utilisant des materiaux optiques textures en surface
PCT/US2004/036460 WO2005042795A2 (fr) 2003-10-31 2004-11-01 Polymerisation par plasma de surfaces ayant subi une modification atomique

Country Status (2)

Country Link
US (4) US20050250156A1 (fr)
WO (3) WO2005041893A2 (fr)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7432060B2 (en) 2000-11-09 2008-10-07 The Brigham And Women's Hospital, Inc. Methods for diagnosis of cardiovascular disease
US7892273B2 (en) 2001-12-03 2011-02-22 Xtent, Inc. Custom length stent apparatus
US20040186551A1 (en) 2003-01-17 2004-09-23 Xtent, Inc. Multiple independent nested stent structures and methods for their preparation and deployment
US7351255B2 (en) 2001-12-03 2008-04-01 Xtent, Inc. Stent delivery apparatus and method
US7137993B2 (en) 2001-12-03 2006-11-21 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US7147656B2 (en) 2001-12-03 2006-12-12 Xtent, Inc. Apparatus and methods for delivery of braided prostheses
PT3072978T (pt) 2002-05-09 2018-10-15 Brigham & Womens Hospital Inc 1l1rl-1 como um marcador de doença cardiovascular
US20050250156A1 (en) * 2003-10-31 2005-11-10 Shebuski Ronald J Detection of acute myocardial infarction biomarkers
EP1530047A1 (fr) * 2003-11-07 2005-05-11 Roche Diagnostics GmbH Marqueurs proximaux de la thrombose arterielle et de l'inflammation pour la stratification de risque d'une maladie cardiaque coronaire
US7326236B2 (en) 2003-12-23 2008-02-05 Xtent, Inc. Devices and methods for controlling and indicating the length of an interventional element
US7323006B2 (en) 2004-03-30 2008-01-29 Xtent, Inc. Rapid exchange interventional devices and methods
US20050288766A1 (en) * 2004-06-28 2005-12-29 Xtent, Inc. Devices and methods for controlling expandable prostheses during deployment
US8317859B2 (en) 2004-06-28 2012-11-27 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
DE602005001299T2 (de) * 2004-07-07 2008-02-07 Roche Diagnostics Gmbh Kombinationen von Markern zum Nachweis von typ 1 und 2 Diabetes
US7410614B2 (en) * 2004-07-26 2008-08-12 Kabushiki Kaisha Toshiba Optical waveguide type iontophoresis sensor chip and method for packaging sensor chip
US7545272B2 (en) 2005-02-08 2009-06-09 Therasense, Inc. RF tag on test strips, test strip vials and boxes
GB0505367D0 (en) * 2005-03-16 2005-04-20 Combining Co The Ltd A method for producing a grafted polymer coating
US20100261288A1 (en) * 2005-06-13 2010-10-14 Fortebio, Inc. Tip tray assembly for optical sensors
EP1929295A4 (fr) * 2005-08-30 2010-03-17 Biosite Inc Utilisation de flt-1 soluble et de ses fragments dans des etats cardio-vasculaires
CA2646885A1 (fr) 2006-03-20 2007-09-27 Xtent, Inc. Appareil et procedes destines a la mise en place de segments prothetiques relies entre eux
ATE527544T1 (de) 2006-04-24 2011-10-15 Critical Care Diagnostics Inc Vorhersage von letalität und detektion von schweren erkrankungen
EP2021799B1 (fr) * 2006-04-27 2011-07-20 Critical Care Diagnostics, Inc. Interleukine-33 (il-33) utilisée pour le diagnostic et le pronostic des maladies cardiovasculaires
AU2011203031B2 (en) * 2006-05-01 2013-12-12 Critical Care Diagnostics, Inc. Diagnosis of cardiovascular disease
ATE545032T1 (de) * 2006-05-01 2012-02-15 Critical Care Diagnostics Inc Diagnose von herz-kreislauf-erkrankung
PL2019965T3 (pl) 2006-05-02 2015-10-30 Critical Care Diagnostics Inc Rozpoznawanie różnicowe chorób układu oddechowego i sercowo-naczyniowego
US20070281117A1 (en) * 2006-06-02 2007-12-06 Xtent, Inc. Use of plasma in formation of biodegradable stent coating
US7935498B2 (en) * 2006-07-07 2011-05-03 Siemens Healthcare Diagnostics Inc. Methods for identifying patients with increased risk of an adverse cardiovascular event
US7382944B1 (en) 2006-07-14 2008-06-03 The United States Of America As Represented By The Administration Of The National Aeronautics And Space Administration Protective coating and hyperthermal atomic oxygen texturing of optical fibers used for blood glucose monitoring
US7376303B2 (en) * 2006-07-20 2008-05-20 Hewlett-Packard Development Company, L.P. Optical coupling assembly
EP1903339B1 (fr) * 2006-09-20 2010-08-04 Roche Diagnostics GmbH Les peptides natriurétiques et le facteur de croissance placentaire ou le recepteur soluble du VEGF permettent de distinguer entre la dysfonction cardiaque causée par une maladie cardiaque et la dysfonction cardiaque causée par le placenta
US20080199510A1 (en) 2007-02-20 2008-08-21 Xtent, Inc. Thermo-mechanically controlled implants and methods of use
US8486132B2 (en) 2007-03-22 2013-07-16 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
DK2198307T3 (da) * 2007-09-13 2012-09-24 Hoffmann La Roche Myoglobin som en tidlig indikator for myocardie-infarkt
AT505883B1 (de) * 2007-10-10 2012-10-15 Greiner Bio One Gmbh Oberflächenmodifikation
US20090219509A1 (en) * 2008-02-29 2009-09-03 Hiroshi Nomura Optical sensor with enhanced reflectance
US8008068B2 (en) * 2008-02-29 2011-08-30 Light Pointe Medical, Inc. Nonhemolytic optical sensor with enhanced reflectance
US9101503B2 (en) 2008-03-06 2015-08-11 J.W. Medical Systems Ltd. Apparatus having variable strut length and methods of use
PL2269063T3 (pl) 2008-04-18 2014-04-30 Critical Care Diagnostics Inc Rokowanie ryzyka głównych niekorzystnych zdarzeń sercowych
DE102010011560B4 (de) * 2010-03-16 2021-09-16 Gilupi Gmbh Biodetektor
EP2686689B1 (fr) 2011-03-17 2019-08-07 Critical Care Diagnostics, Inc. Procédés de prédiction de risque d'un résultat clinique indésirable
CN102346191B (zh) * 2011-06-17 2013-09-11 福建省农业科学院畜牧兽医研究所 番鸭小鹅瘟病乳胶凝集试剂及其制备方法
CN102426238B (zh) * 2011-09-07 2013-09-04 福建省农业科学院畜牧兽医研究所 一种检测番鸭小鹅瘟病免疫荧光试剂
EP2592420B1 (fr) * 2011-11-10 2017-09-20 InfanDx AG Procédé et utilisation de composés métaboliques pour diagnostiquer un accident vasculaire cérébral
US9244237B2 (en) * 2012-02-06 2016-01-26 Tyco Electronics Corporation Optical fiber with resilient jacket
EP2647726A1 (fr) 2012-04-05 2013-10-09 Universitätsklinikum Freiburg Biomarqueurs cardiovasculaires
CN109212223B (zh) 2012-05-18 2021-11-12 重症监护诊断股份有限公司 用于治疗或预报室性快速性心律失常事件风险的方法
MX358541B (es) 2012-08-16 2018-08-24 Critical Care Diagnostics Inc Metodos para predecir el riesgo de desarrollar hipertension.
CN111834009A (zh) 2012-08-21 2020-10-27 重症监护诊断股份有限公司 多标记风险分层
US20140113833A1 (en) * 2012-10-18 2014-04-24 The Cleveland Clinic Foundation Use of multiple risk predictors for diagnosis of cardiovascular disease
CN103123319B (zh) * 2012-12-20 2015-04-15 武汉生之源生物科技有限公司 心型脂肪酸结合蛋白含量检测试剂盒及其制备方法
US20160116472A1 (en) * 2013-02-04 2016-04-28 The General Hospital Corporation Biomarkers for stroke diagnosis
US10371622B2 (en) 2013-03-14 2019-08-06 Inguran, Llc Device for high throughput sperm sorting
US10662408B2 (en) 2013-03-14 2020-05-26 Inguran, Llc Methods for high throughput sperm sorting
US9267897B2 (en) 2013-10-18 2016-02-23 Light Pointe Medical, Inc. Optical sensor element for analyte assay in a biological fluid, and method of manufacture thereof
KR20150078515A (ko) * 2013-12-31 2015-07-08 삼성디스플레이 주식회사 반응성 메조겐의 반응률 측정 방법
DE102014008369A1 (de) * 2014-06-05 2015-12-17 Rosenberger-Osi Gmbh & Co. Ohg Endflächenbeschichtung eines Wellenleiters
US20160178526A1 (en) * 2014-12-18 2016-06-23 Light Pointe Medical, Inc. Optical Sensor Device for Repetitive Assays in Biological Fluids
WO2016123163A2 (fr) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarqueurs de maladies vasculaires
WO2017079741A1 (fr) 2015-11-05 2017-05-11 Wayne State University Trousses et méthodes de prédiction et de traitement de l'éclampsisme
CN106153927A (zh) * 2016-04-12 2016-11-23 上海奥普生物医药有限公司 一种快速定量同时检测cTnI、CKMB、Myo的时间分辨荧光免疫层析试剂及制备方法
US11712177B2 (en) * 2019-08-12 2023-08-01 Essenlix Corporation Assay with textured surface
US20210193441A1 (en) * 2019-12-18 2021-06-24 Jiangsu Favored Nanotechnology Co., Ltd. Coating Apparatus and Coating Method
US11898248B2 (en) * 2019-12-18 2024-02-13 Jiangsu Favored Nanotechnology Co., Ltd. Coating apparatus and coating method
US20210287869A1 (en) * 2020-03-10 2021-09-16 Jiangsu Favored Nanotechnology Co., Ltd. Coating Apparatus and Coating Method
CN113774363A (zh) * 2020-06-09 2021-12-10 江苏菲沃泰纳米科技股份有限公司 镀膜设备及其镀膜方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250264A (en) * 1991-01-25 1993-10-05 Trustees Of Tufts College Method of making imaging fiber optic sensors to concurrently detect multiple analytes of interest in a fluid sample
US5814524A (en) * 1995-12-14 1998-09-29 Trustees Of Tufts College Optical sensor apparatus for far-field viewing and making optical analytical measurements at remote locations
US6319468B1 (en) * 1995-06-27 2001-11-20 Tecan Trading Ag Affinity binding-based system for detecting particulates in a fluid
US6569624B1 (en) * 1999-08-12 2003-05-27 Wisconsin Alumni Research Foundation Identification of genetic markers of biological age and metabolism
US6824816B2 (en) * 2002-01-29 2004-11-30 Asm International N.V. Process for producing metal thin films by ALD

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075493A (en) * 1976-12-16 1978-02-21 Ronald Alves Optical temperature measurement technique utilizing phosphors
JPS61213221A (ja) * 1985-03-19 1986-09-22 Japan Synthetic Rubber Co Ltd プラズマ重合膜の製法
AU5815886A (en) * 1985-05-29 1986-12-24 Kurt Tiefenthaler Optical sensor for selectively determining the presence of substances and the variation of the refraction index in the measured substances
US4706677A (en) * 1985-09-23 1987-11-17 Spectramed, Inc. Multiple sensor bundle
US4935346A (en) * 1986-08-13 1990-06-19 Lifescan, Inc. Minimum procedure system for the determination of analytes
US5055316A (en) * 1988-04-20 1991-10-08 Washington Research Foundation Tight binding of proteins to surfaces
WO1991002975A1 (fr) * 1989-08-21 1991-03-07 The Board Of Regents Of The University Of Washington Detecteur de diagnostic a sondes multiples
US5349181A (en) * 1993-07-26 1994-09-20 Fci-Fiberchem, Inc. Fiber optic chemical sensor having specific channel connecting design
US5472509A (en) * 1993-11-30 1995-12-05 Neomecs Incorporated Gas plasma apparatus with movable film liners
US5439736A (en) * 1994-01-21 1995-08-08 Neomecs Incorporated Gas plasma polymerized permselective membrane
US6022602A (en) * 1994-01-26 2000-02-08 Neomecs Incorporated Plasma modification of lumen surface of tubing
US5609907A (en) * 1995-02-09 1997-03-11 The Penn State Research Foundation Self-assembled metal colloid monolayers
US5639375A (en) * 1995-03-01 1997-06-17 Neomecs Incorporated Concentration of pesticides by membrane perstraction
US5560781A (en) * 1995-05-08 1996-10-01 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Process for non-contact removal of organic coatings from the surface of paintings
US5843789A (en) * 1995-05-16 1998-12-01 Neomecs Incorporated Method of analysis of genomic biopolymer and porous materials for genomic analyses
US6033582A (en) * 1996-01-22 2000-03-07 Etex Corporation Surface modification of medical implants
DE69729185T2 (de) * 1996-03-29 2004-11-25 Radiometer Medical A/S Sensor und modifizierte Membran für diesen Sensor
WO1998020155A1 (fr) * 1996-11-08 1998-05-14 New York Society For The Relief Of The Ruptured And Crippled Maintaining The Hospital For Special Surgery Procede de diagnostic faisant appel a un dosage de ligand cd40
US20020061532A1 (en) * 1997-02-14 2002-05-23 Mosaic Technologies, Inc. Method and apparatus for performing amplification of nucleic acids on supports
US5859937A (en) * 1997-04-04 1999-01-12 Neomecs Incorporated Minimally invasive sensor
EP1059544B1 (fr) * 1998-02-24 2003-06-04 Mitsubishi Rayon Co., Ltd. Fibre optique plastique, cable optique, cable optique possedant une prise, procede servant a preparer un polymere a base de methylmetacrylate et procede servant a fabriquer une fibre optique plastique
JP2000039401A (ja) * 1998-03-24 2000-02-08 Dainippon Printing Co Ltd 表面プラズモン共鳴バイオセンサ―用測定セル及びその製造方法
US6203850B1 (en) * 1999-05-18 2001-03-20 Neomecs Incorporated Plasma-annealed porous polymers
CA2453141A1 (fr) * 2001-07-09 2003-01-23 Arizona Board Of Regents A Body Corporate Acting On Behalf Of Arizona State University Biocapteur d'affinite destine a la surveillance de procedes biologiques
US6597111B2 (en) * 2001-11-27 2003-07-22 Universal Display Corporation Protected organic optoelectronic devices
US20050250156A1 (en) * 2003-10-31 2005-11-10 Shebuski Ronald J Detection of acute myocardial infarction biomarkers

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250264A (en) * 1991-01-25 1993-10-05 Trustees Of Tufts College Method of making imaging fiber optic sensors to concurrently detect multiple analytes of interest in a fluid sample
US6319468B1 (en) * 1995-06-27 2001-11-20 Tecan Trading Ag Affinity binding-based system for detecting particulates in a fluid
US5814524A (en) * 1995-12-14 1998-09-29 Trustees Of Tufts College Optical sensor apparatus for far-field viewing and making optical analytical measurements at remote locations
US6569624B1 (en) * 1999-08-12 2003-05-27 Wisconsin Alumni Research Foundation Identification of genetic markers of biological age and metabolism
US6824816B2 (en) * 2002-01-29 2004-11-30 Asm International N.V. Process for producing metal thin films by ALD

Also Published As

Publication number Publication date
WO2005043123A3 (fr) 2005-06-16
US20050250156A1 (en) 2005-11-10
US20090252649A1 (en) 2009-10-08
WO2005043123A2 (fr) 2005-05-12
WO2005041893A2 (fr) 2005-05-12
US20050123451A1 (en) 2005-06-09
WO2005042795A2 (fr) 2005-05-12
WO2005042795A3 (fr) 2006-06-08
US20060257558A1 (en) 2006-11-16

Similar Documents

Publication Publication Date Title
WO2005041893A3 (fr) Detection des biomarqueurs de l'infarctus aigu du myocarde
WO2008135862A3 (fr) Dispositifs et procédés pour détecter des analysats
HK1120568A1 (en) Biosensors for detecting macromolecules and other analytes
PT1776587E (pt) Utilização de c3a e seus derivados como biomarcador para o adenoma e/ou carcinoma colorrectal; processos de diagnóstico e ensaios utilizando os mesmos
WO2007030949A3 (fr) Procedes de diagnostic de cancer des ovaires et necessaires a cet effet
EP2177614A3 (fr) Composition et procédé permettant de diagnostiquer un cancer oesophagien et une métastase d'un cancer oesophagien
WO2010033371A3 (fr) Marqueurs moléculaires pour les carcinomes pulmonaires et colorectaux
WO2007127749A3 (fr) Prédiction de la mortalité et détection d'une maladie grave
ATE425266T1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
WO2008008284A3 (fr) Biomarqueurs du cancer et méthodes d'utilisation
CY1113686T1 (el) Συσκευη bio-αισθητηρα και οι μεθοδοι χρησης της
EP2026071A3 (fr) Identification de biomarqueurs de protéines du cancer en utilisant des techniques protéomiques
WO2005010494A3 (fr) Detection d'analytes multiplexee
WO2001018252A3 (fr) Methodes de detection de maladies
HK1123847A1 (en) A device for detecting the presence or amount of an analyte in a fluid sample and method thereof
WO2003016527A3 (fr) Procede permettant de detecter un stress oxydatif et trousse destinee a la mise en oeuvre de ce procede
WO2004112570A3 (fr) Detection de la survivine dans les liquides organiques de patients cancereux
WO2008054764A3 (fr) Biomarqueurs pour cancer colorectal
WO2007048084A3 (fr) Analyse judiciaire de salive humaine
WO2008124091A3 (fr) Compositions et procédés de détection
WO2004057336A3 (fr) Utilisation de la nicotinamide n-methyltransferase comme marqueur du cancer colorectal
WO2007094805A3 (fr) Procédé de détection électrocatalytique de protéines
AU2003289853A8 (en) Methods, device and instrument for detection of analytes
WO2007092552A3 (fr) Dispositif et procédés de détection et de quantification d'un ou plusieurs agents cibles
WO2006066917A3 (fr) Utilisation de la proteine asc comme marqueur du cancer colorectal

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase